Clinical Characteristics of RA Patients with Secondary SS and Association with Joint Damage

Overview

Journal Rheumatology (Oxford)

Publisher Oxford University Press

Specialty Rheumatology

Date 2014 Oct 15

PMID 25313147

Citations 23

Authors

Lindsay E Brown

Michelle L Frits

Christine K Iannaccone

Michael E Weinblatt

Nancy A Shadick

Katherine P Liao

Affiliations

Soon will be listed here.

Abstract

Objectives: Secondary SS (sSS) is a common extra-articular manifestation of RA. There are conflicting data regarding the association of sSS with worse joint damage. This study aims to characterize sSS patients in an RA cohort and study the association between sSS and joint damage.

Methods: We conducted a cross-sectional study of RA patients with ≥1 year of follow-up at a large academic centre. Subjects with co-morbid diseases that can also result in sicca symptoms were excluded from the analysis. Subjects were considered to have sSS if they were reported as having sSS by their rheumatologist at recruitment into the cohort and had the diagnosis confirmed by chart review. The primary outcome was Sharp score using bilateral hand radiographs at recruitment. We constructed a linear regression model to determine the association of sSS status and Sharp score adjusted by age, gender, disease duration and ACPA and RF status.

Results: We studied 829 RA subjects, mean age 57 years, 83% female, mean RA duration 13 years, 74% seropositive; 85 subjects (10.3%) had sSS. We observed a female predominance (95.3%), longer mean disease duration (16.9 years) and higher frequency of RF or ACPA positive among patients with sSS and RA. Having sSS at baseline was associated with higher Sharp scores (P = 0.03), independent of age, gender, RA disease duration and seropositive disease.

Conclusion: In our RA cohort, RA subjects with sSS had worse joint damage, suggesting that sSS is a marker of more aggressive disease.

Citing Articles

Epidemiology of Sjogren's syndrome in a sample of the Egyptian population: a cross-sectional study.

Ghalwash D, El-Gawish A, Ammar A, Hamdy A, Ghanem R, Ghanem M J Int Med Res. 2024; 52(10):3000605241289292.

PMID: 39387202 PMC: 11475091. DOI: 10.1177/03000605241289292.

Polyarthritis in Sjögren's Syndrome: Difficulties in Distinguishing Extraglandular Manifestation and Associated Rheumatoid Arthritis.

Aradi Z, Nagy G, Horvath I, Antal-Szalmas P, Szanto A Diagnostics (Basel). 2024; 14(14).

PMID: 39061631 PMC: 11275481. DOI: 10.3390/diagnostics14141494.

Investigating the Effectiveness of a Carb-Free Oloproteic Diet in Fibromyalgia Treatment.

Castaldo G, Marino C, Atteno M, DElia M, Pagano I, Grimaldi M Nutrients. 2024; 16(11).

PMID: 38892552 PMC: 11175073. DOI: 10.3390/nu16111620.

Concomitant Sjögren's disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss clinical quality management cohort.

Christ L, Kissling S, Finckh A, Fisher B, Adler S, Maurer B Arthritis Res Ther. 2024; 26(1):68.

PMID: 38481302 PMC: 10938669. DOI: 10.1186/s13075-024-03302-z.

Choroidal, retinal, and optic nerve changes in rheumatoid arthritis and primary sjogren's syndrome patients: comparıson with each other and healthy subjects.

Kiyat P, Karti O, Gercik O, Sak T Int Ophthalmol. 2024; 44(1):24.

PMID: 38324105 DOI: 10.1007/s10792-024-02970-9.

References

Boini S, Guillemin F . Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages. Ann Rheum Dis. 2001; 60(9):817-27. PMC: 1753828. View

Shiboski S, Shiboski C, Criswell L, Baer A, Challacombe S, Lanfranchi H . American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2012; 64(4):475-87. PMC: 3349440. DOI: 10.1002/acr.21591. View

Liao K, Weinblatt M, Cui J, Iannaccone C, Chibnik L, Lu B . Clinical predictors of erosion-free status in rheumatoid arthritis: a prospective cohort study. Rheumatology (Oxford). 2011; 50(8):1473-9. PMC: 3133482. DOI: 10.1093/rheumatology/ker129. View

Kauppi M, Pukkala E, Isomaki H . Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control. 1997; 8(2):201-4. DOI: 10.1023/a:1018472213872. View

Barcelos F, Abreu I, Vaz Patto J, Trindade H, Teixeira A . Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Sjögren's syndrome. Acta Reumatol Port. 2010; 34(4):608-12. View

Drosos A, Lanchbury J, Panayi G, Moutsopoulos H . Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiologic, and serologic study. Arthritis Rheum. 1992; 35(7):745-8. DOI: 10.1002/art.1780350705. View

Iannaccone C, Lee Y, Cui J, Frits M, Glass R, Plenge R . Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study. Rheumatology (Oxford). 2010; 50(1):40-6. DOI: 10.1093/rheumatology/keq263. View

Syversen S, Gaarder P, Goll G, Odegard S, Haavardsholm E, Mowinckel P . High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis. 2007; 67(2):212-7. DOI: 10.1136/ard.2006.068247. View

Tsampoulas C, Skopouli F, Sartoris D, Kaplan P, Kursunoglu S, Pineda C . Hand radiographic changes in patients with primary and secondary Sjögren's syndrome. Scand J Rheumatol. 1986; 15(3):333-9. DOI: 10.3109/03009748609092600. View

10.

Marotte H, Farge P, Gaudin P, Alexandre C, Mougin B, Miossec P . The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction. Ann Rheum Dis. 2005; 65(7):905-9. PMC: 1798215. DOI: 10.1136/ard.2005.036913. View

11.

Moutsopoulos H, Webber B, Vlagopoulos T, Chused T, Decker J . Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med. 1979; 66(5):733-6. DOI: 10.1016/0002-9343(79)91110-0. View

12.

Hadj Kacem H, Kaddour N, Adyel F, Bahloul Z, Ayadi H . HLA-DQB1 CAR1/CAR2, TNFa IR2/IR4 and CTLA-4 polymorphisms in Tunisian patients with rheumatoid arthritis and Sjögren's syndrome. Rheumatology (Oxford). 2001; 40(12):1370-4. DOI: 10.1093/rheumatology/40.12.1370. View

13.

Haga H, Naderi Y, Moreno A, Peen E . A study of the prevalence of sicca symptoms and secondary Sjögren's syndrome in patients with rheumatoid arthritis, and its association to disease activity and treatment profile. Int J Rheum Dis. 2012; 15(3):284-8. DOI: 10.1111/j.1756-185X.2012.01717.x. View

14.

He J, Ding Y, Feng M, Guo J, Sun X, Zhao J . Characteristics of Sjögren's syndrome in rheumatoid arthritis. Rheumatology (Oxford). 2013; 52(6):1084-9. DOI: 10.1093/rheumatology/kes374. View

15.

Sokka T . Radiographic scoring in rheumatoid arthritis: a short introduction to the methods. Bull NYU Hosp Jt Dis. 2008; 66(2):166-8. View

16.

Theander E, Jacobsson L . Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders. Rheum Dis Clin North Am. 2008; 34(4):935-47, viii-ix. DOI: 10.1016/j.rdc.2008.08.009. View

17.

Uhlig T, Kvien T, Jensen J, Axell T . Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis. Ann Rheum Dis. 1999; 58(7):415-22. PMC: 1752918. DOI: 10.1136/ard.58.7.415. View

18.

Vitali C, Bombardieri S, Jonsson R, Moutsopoulos H, Alexander E, Carsons S . Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002; 61(6):554-8. PMC: 1754137. DOI: 10.1136/ard.61.6.554. View